These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3957968)

  • 21. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permacol (porcine dermal collagen) and Alloderm (acellular cadaveric dermis) as a vascular patch repair for common carotid arteriotomy in a rabbit model.
    Tsai JW; Ayubi FS; Rice RD; Zhang Z; Armstrong PJ
    Ann Vasc Surg; 2009; 23(3):374-81. PubMed ID: 19059755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful animal study of small caliber heparin-protamine-collagen vascular grafts.
    Noishiki Y; Miyata T
    Trans Am Soc Artif Intern Organs; 1985; 31():102-6. PubMed ID: 3837424
    [No Abstract]   [Full Text] [Related]  

  • 24. [Polymers modified by biologically active compounds--a new type of compatible material for contact with the blood].
    Platé NA; Valuev LI; Chutov VV; Burdygina IF
    Vopr Med Khim; 1985; 31(4):43-7. PubMed ID: 4049785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can protamine be used during perfusion with heparin surface coated equipment?
    von Segesser LK; Gyurech DD; Schilling JJ; Marquardt K; Turina MI
    ASAIO J; 1993; 39(3):M190-4. PubMed ID: 8268526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An improved method for electron microscopic study (SEM and TEM) of vessel prosthesis anastomoses in microsurgery.
    Durand M; Arrouvel C; Banzet P
    J Submicrosc Cytol; 1985 Jul; 17(3):429-34. PubMed ID: 4020926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonthrombogenic small-caliber human umbilical vein vascular prosthesis.
    Venkataramani ES; Senatore F; Feola M; Tran RM
    Surgery; 1986 Jun; 99(6):735-43. PubMed ID: 3086995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of an epoxy-fixed pericardial patch with or without ionically bound heparin in a canine model.
    Chang Y; Sung H; Chiu Y; Lu J
    Int J Artif Organs; 1997 Jun; 20(6):332-40. PubMed ID: 9259210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparinization on pericardial substitutes can reduce adhesion and epicardial inflammation in the dog.
    Lu JH; Chang Y; Sung HW; Chiu YT; Yang PC; Hwang B
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1111-20. PubMed ID: 9605081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term behavior of bovine collagen membrane used as vascular substitute. Experimental study in rats.
    Chignier E; Eloy R; Huc A; Gimeno R; Gleizal C
    J Biomed Mater Res; 1985 Feb; 19(2):115-31. PubMed ID: 4077875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of fibrinogen in protamine-induced pulmonary hypertension.
    Sogawa M; Mohammad SF
    J Surg Res; 1997 Nov; 73(1):80-4. PubMed ID: 9441797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Titrimetric method for determination of O-desulfated heparin in physiological samples using protamine-sensitive membrane electrode as endpoint detector.
    Buchanan SA; Kennedy TP; MacArthur RB; Meyerhoff ME
    Anal Biochem; 2005 Nov; 346(2):241-5. PubMed ID: 16213460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
    Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat.
    Weening JJ; Grond J; Hoedemaeker PJ
    Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new antithrombogenic heparinized polymer.
    Miyama H; Harumiya N; Mori Y; Tanzawa H
    J Biomed Mater Res; 1977 Mar; 11(2):251-65. PubMed ID: 856815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for improving the functionality of an affinity bioreactor.
    Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
    Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorometric determination of heparin based on self-quenching of fluorescein-labeled protamine.
    Egawa Y; Hayashida R; Seki T; Anzai J
    Talanta; 2008 Aug; 76(4):736-41. PubMed ID: 18656650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin bioconjugate with a thermoresponsive cationic branched polymer: a novel aqueous antithrombogenic coating material.
    Nakayama Y; Okahashi R; Iwai R; Uchida K
    Langmuir; 2007 Jul; 23(15):8206-11. PubMed ID: 17571905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation.
    Mohamed MS; Mukherjee M; Kakkar VV
    J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.